title: Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses.
authors.affiliation: Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, University of Western Ontario, 1400 Western Rd, London, ON, Canada N6G 2V2. dspence@robarts.ca
authors.forename: J David
authors.initials: JD
authors.lastname: Spence
authors.forename: Meir J
authors.initials: MJ
authors.lastname: Stampfer
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D015201:Meta-Analysis as Topic; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000235:genetics / Q000378:metabolism; D011110:Polymorphism, Genetic; D015203:Reproducibility of Results; D018570:Risk Assessment; D020521:Stroke / Q000097:blood / Q000517:prevention & control; D014805:Vitamin B 12 / Q000493:pharmacokinetics / Q000627:therapeutic use; D014806:Vitamin B 12 Deficiency; D014803:Vitamin B Complex / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D006710:Homocysteine; D014803:Vitamin B Complex; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP); D014805:Vitamin B 12